Characterization of the metabolites of rosmarinic acid in human liver microsomes using liquid chromatography combined with electrospray ionization tandem mass spectrometry. (13th February 2020)

• Record Type: Journal Article
• Authors: Su, Jing; Jia, Fangyuan; Lu, Junjie; Chen, Weixu; Sun, Han; Liu, Tong; Wu, Xia
• Is Part Of: Biomedical chromatography. Volume 34:Number 4(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-02-13
• Subjects: bioactivation -- human liver microsomes -- metabolite characterization -- rosmarinic acid; Chromatographic analysis -- Periodicals; Biology -- Periodicals; Medicine -- Periodicals; Biology -- Periodicals; Chromatography -- methods -- Periodicals; Medicine -- Periodicals; 543.089
• DOI: 10.1002/bmc.4806
• Languages: English
• ISSNs: 0269-3879

Abstract

Abstract: Rosmarinic acid (RA) is a phenolic acid originally isolated from the herb medicine Rosmarinus officinalis . The purpose of this study was to identify the metabolites of RA. RA was incubated with human liver microsomes in the presence of β‐nicotinamide adenine dinucleotide phosphate tetrasodium salt and/or uridine diphosphate glucuronic acid using glutathione (GSH) as a trapping agent. After 60‐min incubation, the samples were analyzed using high‐resolution liquid chromatography tandem mass spectrometry. Under the current conditions, 14 metabolites were detected and identified. Our data revealed that RA was metabolized through the following pathways: the first pathway is the oxidation of catechol to form ortho ‐quinone intermediates, which react with GSH to form mono‐GSH adducts (M1, M2, and M3) and bis ‐GSH adducts (M4 and M5); the second pathway is conjugation with glucuronide to yield acylglucuronide (M7), which further reacts with GSH to form RA‐ S ‐acyl‐GSH adduct (M9); the third pathway is hydroxylation to form M10, M11, and M12, which further react with GSH to form mono‐GSH adducts (M13 and M14); the fourth pathway is conjugation with GSH through Michael addition (M6); the fifth pathway is conjugation with glucuronidation, forming M8, which is the major metabolic pathway of RA.